Croatia vs Saint Kitts and Nevis: Prevalence of hypertension, female
Croatia
45.3%
in 2019
Saint Kitts and Nevis
45.1%
in 2019
Croatia rank
19th
Saint Kitts and Nevis rank
21st
Prevalence of hypertension, female over time
- Croatia
- Saint Kitts and Nevis
How they compare
Croatia currently reports 45.3% against 45.1% in Saint Kitts and Nevis, a difference of 0.2%.
Across all 30 years both countries report, Croatia has been ahead every year.
Croatia ranks 19th and Saint Kitts and Nevis ranks 21st of 192 countries.
Croatia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Croatia | Saint Kitts and Nevis | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 45.7% | 39.3% | 6.4% | Croatia |
| 2000s | 43.5% | 42.3% | 1.2% | Croatia |
| 2010s | 44.9% | 44.7% | 0.2% | Croatia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, female, Croatia or Saint Kitts and Nevis?
- Croatia, at 45.3% against 45.1% in Saint Kitts and Nevis as of 2019.
- What is the difference in prevalence of hypertension, female between Croatia and Saint Kitts and Nevis?
- 0.2%, with Croatia ahead.
- How many years of comparable data are there for Croatia and Saint Kitts and Nevis?
- 30 years are reported by both, from 1990 to 2019.
- How do Croatia and Saint Kitts and Nevis rank globally for prevalence of hypertension, female?
- Croatia ranks 19th and Saint Kitts and Nevis ranks 21st of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension, female (% of female adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension, female, is the percentage of female adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.